Previous close | 0.1400 |
Open | 0.1400 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 190.00 |
Expiry date | 2025-01-17 |
Day's range | 0.1400 - 0.1400 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
Q1 2024 Eli Lilly and Co Earnings Call
Discover how Eli Lilly and Co (LLY) achieved impressive Q1 results and raised its 2024 outlook, driven by strong product performance and strategic expansions.